id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-276361-77cylm1o	Yamamoto, Norio	HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus	2004-06-04		.txt	text/plain	2267	129	55	title: HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus Here we report that the HIV-1 protease inhibitor, nelfinavir, strongly inhibited replication of the SARS coronavirus (SARS-CoV). Experiments with various timings of drug addition revealed that nelfinavir exerted its effect not at the entry step, but at the post-entry step of SARS-CoV infection. We found that nelfinavir, a widely used HIV-1 protease inhibitor, could inhibit SARS-CoV replication efficiently. We screened our chemical library and found that nelfinavir could inhibit SARS-CoV replication in Vero E6 cells. Nelfinavir clearly inhibited the cytopathic effect (CPE) induced by infection with SARS-CoV (Fig. 1A) . Nelfinavir significantly inhibited SARS-CoV replication when used before infection (Figs. The other protease inhibitors including ritonavir had no effect on replication of SARS-CoV CC 50 , cytotoxic concentration of the compound that reduced cell viability to 50%. Our studies have clearly shown that nelfinavir can strongly inhibit the replication of SARS-CoV in Vero E6 cells.	./cache/cord-276361-77cylm1o.txt	./txt/cord-276361-77cylm1o.txt